Cystic Fibrosis Market, [by Product Type (Ventolin, Orkambi, Kalydeco, Cayson, Pulmozyme, TOBI Podhaler, Ibuprofen, ADEKplusTM, Creon, Zenpep, Bronchiole)]; and Geography - Trend, Analysis and Forecast till 2025

报告摘要

该全球囊性纤维化市场尺寸主要受到患有患有囊性纤维化的患者的因素，以及患有患有CF的个体的诊断率上升的因素。

囊性纤维化(CF)主要影响肺部,但肌萎缩性侧索硬化症o can affect pancreas, kidney, liver and intestine. It is a genetic disorder which is characterised by long-term issues of breathing and frequent lung infection. CF generally affects cell and produces mucus, sweat, and digestive cells. In individuals suffering from cystic fibrosis, gene causes secretion to become sticky and thick instead of acting as a lubricant. Cystic fibrosis’ symptoms vary according to the severity of disease; for instance, a person may notice worse symptoms which may be improved as time passes. While, some may not notice the symptoms until adolescence or adulthood. Increasing number of patients suffering from cystic fibrosis, and lack of awareness in the developing countries are the major factors that are driving the CF market globally. According to cystic fibrosis foundation, more than 30,000 people in the U.S. are living with CF and around 70,000 people are suffering from CF worldwide.

囊性纤维化的个体通常在其汗水中具有高盐水平，而液体又影响了呼吸系统和消化系统。类似地，患有囊性纤维化的成年人可能患有非典型症状，例如胰腺炎，致病性肺炎和不孕症。囊性纤维化是一种缺陷，其是由基因变化引起的，该缺陷会调节盐从体细胞的外部运动。北欧祖先种族的白人最有可能受到CF的影响。

预计持续研究和开发导致的技术转变将支持全球囊性纤维化市场的增长。

囊性纤维化市场主要由患有患有囊性纤维化的患者的因素驱动，以及患有患有CF的个体的诊断率上升。此外，越来越多的专利和许可药物和用于治疗囊性纤维化的产品，以及增加生物技术和药品制造商之间的巩固，用于瞄准未开发的市场将影响整个行业。市场上的高机会也为这个市场上存在的小公司创造了良好的空间。

全球囊性纤维化市场分类

该cystic fibrosis market is segmented on the basis of product type, and geography.

On the basis of product type, the global cystic fibrosis market is segmented as:

• Ventolin
• orkambi.
• Kalydeco
• 陶森
• 嘌呤酶
• TOBI Podhaler
• 布洛芬
• adekplustms.
• Creon
• Zenpep
• Bronchitol

地理上，全球囊性纤维化市场分为北美，欧洲，亚太地区，拉丁美洲和中东和非洲。

北美铅纤维化市场增长的技术进步与创新。

在地理的基础上，北美预计将在预测期间主导囊性纤维化市场规模。由于医疗保健支出上升，并增加了对患有该地区CF的患者的越来越多的患者，北美占据了这一市场的大多数份额。betway体育亚洲版入口同样，有利的复杂的医疗保健设施和新药物批准的政府法规将刺激北美囊性纤维化betway体育亚洲版入口市场份额。虽然，欧洲在囊性纤维化市场中占据了第二大份额。

但是，亚太地区在预测期间应该遵守因因素而观察高增长;信息不可用，缺乏治疗囊性纤维化的意识。此外，亚太地区囊性纤维化市场规模预计将受益于改善发展中国家的医疗基础设施。betway体育亚洲版入口

Key players in the global cystic fibrosis market are:

• ABBVIE Inc.
• 极光生物科学
• Bayer Healthcare AG
• Genentech，Inc。
• Aradigm
• 德国
• 指数药物
• Menros治疗方法
• Novartis AG.
• Hoffmann-La Roche AG
• Polydex Pharmaceuticals.